Hibernation for cancer: You wake up the patients and they are cured Say what now?

Feb 22 8:53am Health News Review
A story made the U.K. news rounds this week that most certainly should have been relegated to the editing room floor: Putting cancer patients in hibernation could tackle tumors ~ New Scientist Doctors hope cancer could be CURED in just ten years by putting patients into ‘hibernation’ for just a week ~ The Sun Put patients […]...
Read More
1

The Top 15 Specialty Pharmacies of 2016

Feb 22 7:30am Drug Channels
In 2016, specialty drugs became an even bigger part of the pharmacy industry. We estimate that in 2016, retail, mail, long-term care, and specialty pharmacies dispensed about $115 billion in specialty pharmaceuticals. Specialty drugs accounted for 28\% of the pharmacy industry’s prescription dispensing revenues. Below is our exclusive list of the 15 largest pharmacies, ranked by estimated revenues from dispensing specialty pharmaceuticals. This year’s expanded list includes specialty pharmacies owned by pharmacy benefit managers (PBMs), health plans, retail chains, and wholesalers. A further five pharmacies are independent companies—for now. Lace up and get ready to slug it out with our latest update on the booming specialty market.Read more »Copyright © 2006-2017 Pembroke Consulting, Inc. and Copyright © 2006-2017 Drug Channels. This Feed is for personal non-commercial use only.
Read More
6

FDA grants priority review to Pfizer's antibody-drug conjugate for ALL

Feb 22 5:42am PBR - News
The US Food and Drug Administration (FDA) has granted a priority review designation to Pfizer's anti-CD22 antibody-drug conjugate inotuzumab ozogamicin to treat patients with relapsed or refractory acute lymphoblastic leukemia (ALL).
Read More
8

hVIVO says US body begins trial on malaria and Zika vaccine

Feb 22 5:31am PBR - News
Biopharmaceutical firm hVIVO PLC on Tuesday said the US National Institute of Health has initiated a phase one clinical trial of AGS-v, an investigational vaccine for mosquito-borne diseases like malaria and Zika.
Read More
6

Abzena signs antibody manufacturing development deal with University College London

Feb 22 5:29am PBR - News
Abzena has entered into a manufacturing agreement with University College London (UCL).
Read More
6

European Commission conditionally approves Roches cancer drug Alecensa

Feb 22 12:57am PBR - News
Roche's oral ALK inhibitor, Alecensa, has been conditionally approved in the European Union as a monotherapy for anaplastic lymphoma kinase-positive advanced non-small cell lung cancer (NSCLC) in adults who were earlier treated with crizotinib.
Read More
8

Week 22: Up close and personal

Feb 21 11:00pm Knocked Up – Pregnancy & Newborn Magazine
The highlight of this week is without a doubt my second trimester ultrasound. (That’s the big one!) Lee and I got to see some seriously amazing close-ups of our bitty bean. Honestly, I think I was in awe the whole time, … Continue reading → The post Week 22: Up close and personal appeared first on Pregnancy & Newborn Magazine.
Read More
11

Baby number 2 at age 42

Feb 21 8:27pm pregnancy – Hubbub
Well, when I fell pregnant I was actually 41 if we’re being pedantic about it. Haha. A year makes all the difference now doesn’t it? As the double test strips turned a vibrant blue my internal dialogue went into overdrive, ‘hang on, I’m 42. Oh no. No. Wait. I’m 41 and a half. Born in 1974. So, I’m nearly 42. 41 just now but I’m nearly 42. I’ll be 42 when I give birth. Right yes 42 when I have the baby’. I genuinely had to work out my age. It made me half smile. Having to calculate how old I am. Such a stereotype. Immediately I google ‘celebs baby after 40.’ This helped. Try it, great results and loads of them. I cheered quite a bit. I breathed easier. Plenty of them older than 42 as well. Susan Sarandon was 45 when she had her third and Halle Berry was an extremely fabulous 47 when she welcomed her second baby into the wor...
Read More
11

Gainers & Losers Of The Day: EYEG, BLPH, VSAR, MNTA, AMPH...

Feb 21 7:50pm RTT - Biotech
The FDA has turned down Amphastar's request seeking approval of intranasal Naloxone, proposed for the treatment of opioid addiction or overdose.
Read More
9

A Call For The FDA To Raise The Bar For Clinical Trials Is Flawed

Feb 21 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
2

Serial Investor Takes Stake in Bristol-Myers Squibb, Stock Jumps

Feb 21 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
9

New study shows Zika infectious period ranges from 2 weeks to 3 months

Feb 21 6:48pm
There hasn’t been much in the news recently on the Zika virus. [Perhaps Trump is entertaining enough such that the news folks have enough news (fake or otherwise) to attract readers.] More likely it’s because the Zika virus is transmitted… Read more → The post New study shows Zika infectious period ranges from 2 weeks to 3 months appeared first on Quintessential.
Read More
7

APOP Pops On Study Data, EYEG Catches Investors' Eyes, CDTX Loses Radiance

Feb 21 5:45pm RTT - Biotech
Shares of Cellect Biotechnology Ltd. (APOP) rose over 15\% on Tuesday, following positive final results from its clinical trial of ApoGraft in healthy donors.
Read More
14

12 Things No One Told You About Your Postpartum Body

Feb 21 4:59pm Pregnancy Exercise
Nothing in this world compares to the emotions you feel when you have finally given birth and you can hold your newborn, its a magical moment and one that you will cherish forever. Nevertheless when you are not attending to baby’s needs, your thoughts may wonder to whether your body will ever feel the same again. The after birth process can be quite […]...
Read More
12

Bristol-Myers stock jumps after Carl Icahn reportedly takes a stake

Feb 21 3:39pm Health Care
Shares of Bristol-Myers climbed as much as 4 percent after billionaire Carl Icahn reportedly took a stake in the company, according to Dow Jones.
Read More
14

Accused fraudster Shkreli's co-defendant Greebel blasts him as a serial liar in separate trial bid

Feb 21 2:41pm Health Care
Shkreli is accused of ripping off his former pharma company Retrophin to pay off defrauded hedge-fund investors.
Read More
14

Nesting Instincts: Russian Dolls Make a Magical Gender Reveal

Feb 21 1:30pm Destination Maternity Blog
Ever since I was a little girl I have been fascinated with Matryoshka (Russian) nesting dolls. One wooden doll with another little doll nestled inside… and so on and so on. My mother had a big, beautiful set that my grandmother had brought back with her from a trip to Russia. I loved to play […]...
Read More
33

The Truth About Nuchal Cords (Umbilical Cord Around Babys Neck)

Feb 21 10:41am Pregnancy – Mama Natural
Pregnancy brings with it a veritable dictionary of new terms, and many of them sound ominous. (Lochia, vernix, and port wine stains, oh my!) What about a nuchal cord, or when baby’s umbilical cord is wrapped around their neck)? What is it? Should you stress out over it? Read on for info on why babies […] The post The Truth About Nuchal Cords (Umbilical Cord Around Baby’s Neck) appeared first on Mama Natural.
Read More
38

AmpTec looking to achieve full GMP compliance for APIs

Feb 21 10:20am in-PharmaTechnologist RSS
AmpTec GmbH is in the process of achieving full GMP compliance for API manufacturers in order to expand its offerings into the clinical space.
Read More
30

Licorice & pregnancycaffeine & longer life: Distorted news stories about observational research

Feb 21 8:49am Health News Review
Step back. Breathe deeply. Join us in sucking in some recent research news coverage. Coughing on cacophony of coffee/caffeine news USA Today reported, “Caffeine may lead to a longer life.” Or, it may not, the story could just as easily–and accurately– have reported. Instead, it makes a leap to this news-you-can use assertion: “Perk up. That daily cup […]...
Read More
19

Join me at Asembia's Specialty Pharmacy Summit 2017

Feb 21 7:30am Drug Channels
Specialty Pharmacy Summit 2017April 30 – May 3, 2017Wynn & Encore | Las VegasPlease join me at Asembia's  Specialty Pharmacy Summit 2017, which will take place from April 30 to May 3, 2017, at the wonderful Wynn & Encore Las Vegas.This year, I will help kick things off with an opening Featured Session titled Specialty Pharmaceuticals and Pharmacy: Today, Tomorrow and Beyond. I'll be joined by Doug Long from QuintilesIMS and Eric Percher from Barclays Capital.The Summit attracts an impressive diversity of pharmacies, manufacturers, health plans, wholesalers, hospital systems, pharmacy benefit managers, patient advocacy groups, and more. View the agenda and check out the list of speakers.Here's my review of last year's Summit: The State of Specialty Pharmacy in 2016: Reflections from #Asembia16.Read on for more details about this great specialty pharmacy event a...
Read More
20

Join me at the Asembia's Specialty Pharmacy Summit 2017

Feb 21 7:30am Drug Channels
Specialty Pharmacy Summit 2017April 30 – May 3, 2017Wynn & Encore | Las VegasPlease join me at Asembia's  Specialty Pharmacy Summit 2017, which will take place from April 30 to May 3, 2017, at the wonderful Wynn & Encore Las Vegas.This year, I will help kick things off with an opening Featured Session titled Specialty Pharmaceuticals and Pharmacy: Today, Tomorrow and Beyond. I'll be joined by Doug Long from QuintilesIMS and Eric Percher from Barclays Capital.The Summit attracts an impressive diversity of pharmacies, manufacturers, health plans, wholesalers, hospital systems, pharmacy benefit managers, patient advocacy groups, and more. View the agenda and check out the list of speakers.Here's my review of last year's Summit: The State of Specialty Pharmacy in 2016: Reflections from #Asembia16.Read on for more details about this great specialty pharmacy event a...
Read More
18

In a possible step forward for gene therapy, researchers made mice glow like fireflies

Feb 21 6:59am Nanowerk Biotech News
A collaboration between chemists and gene therapy experts produced a new way of inserting the code for modified proteins into the cells of mice. If successful in humans, the technique could be useful for vaccines or cancer therapies.            ...
Read More
18

Can Craig Venter Cheat Death?

Feb 21 6:00am The Medicine Show
Craig Venter, the man who mapped the human genome, is back with a $25,000 physical he hopes can extend your life--and make him a billionaire.
Read More
7

Cancer drug plant likely source of radio isotope detected across Europe say experts

Feb 21 5:53am in-PharmaTechnologist RSS
A radiopharmaceuticals plant is the most likely source of the radioactive iodine-131 detected in several countries in recent weeks according to experts.
Read More
35

Chi-Med starts phase II study of savolitinib in pulmonary sarcomatoid carcinoma

Feb 21 4:38am PBR - News
Hutchison China MediTech has commenced a phase 2 study of savolitinib in locally advanced or metastatic pulmonary sarcomatoid carcinoma (PSC) in China.
Read More
20

Modus Therapeutics raises 2.9m to support further development of sevuparin for SCD

Feb 21 4:37am PBR - News
Modus Therapeutics has raised SEK32m (£2.9m) from existing investors KDev Investments, Östersjöstiftelsen and Praktikerinvest to support a phase two study of a sickle cell disease (SCD) drug.
Read More
20

Granules to expand Indian API plants and US dosage form site

Feb 21 4:06am in-PharmaTechnologist RSS
Granules India will build an API production facility in Bonthapally, Telangana and expand other manufacturing sites in a project backed by the Word Bank. ...
Read More
40

Faron doses first patent in Traumakins multi-organ failure study

Feb 21 1:03am PBR - News
Faron Pharmaceuticals has dosed the first patient in its study of Traumakine drug for the treatment of multi-organ failure (MOF) and mortality prevention of surgically operated ruptured abdominal aorta aneurysm (RAAA) patients.
Read More
19

Can Craig Venter Cheat Death?

Feb 20 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
39

3 Stocks To Invest In Big Pharma

Feb 20 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
37

Medical Device Reading List (February 20, 2017)

Feb 20 5:45pm
Catch up on last week's major stories, including device manufacturers making a few strategic acquisitions and divestitures, as well as a new indication for Medtronic's ablation line.Johnson & Johnson's Ethicon buys Torax MedicalSeeking Alpha ($JNJ)​Why Edwards Lifesciences Could Bounce BackTodd Campbell, The Motley Fool ($EW)​Medtronic (MDT) Announces Expanded Indication for OsteoCool RF Ablation SystemStreet Insider ($MDT)​Integra Scoops Up JNJ's Codman Neurosurgery UnitAl [...]...
Read More
13

Pregnancy Diary: Scans the Good, the Bad and the Scary

Feb 20 3:46pm Pregnancy Exercise
I marvel every time I get an ultrasound – to me there’s just something so amazing about catching a glimpse of your baby growing in that incredible home your body has made for them (although I admit, a lot of the time I have no idea what the ill-defined blob on the screen actually is, […]...
Read More
17

Unlocking peptide potential

Feb 20 3:30pm Nanowerk Biotech News
New computational methods may enable custom-designed drugs.            ...
Read More
15

We Need to Talk About Postnatal Depression

Feb 20 3:29pm Pregnancy Exercise
A horribly sad incident related to postnatal depression occurred in my wider community recently and it’s really shaken me. I’m not going to talk about the specifics, as it’s not my story to tell, but I can say that it brought home to me in a really vivid way just how cruel this illness is. […]...
Read More
14

Are YOUR lips attractive? Clickbait science fuels clickbait journalism

Feb 20 3:12pm Health News Review
Cancer recurrence. Antibiotic resistance. Heart failure. Attractive lips. All have been the subject of recently published medical research–and subsequent news coverage. Yes, you read that right: The quest for attractive lips is on par with solving heart failure, at least when it comes to deserving a big splashy news release. That’s because apparently, up until last […]...
Read More
16

Pressure and Expectation

Feb 20 3:05pm Pregnancy Exercise
This is an interesting topic, one that I would encounter a lot when racing but didn’t realise I would also encounter when pregnant.  This is my first pregnancy and my priority has always been to stay as healthy as possible, part of this (for me) means incorporating exercise into my daily routine.  I didn’t quite […]...
Read More
17

Headline vs. study: Cancer breath, common weeds, and coffee forever!

Feb 20 12:30pm Health News Review
This is our third go-round looking for disconnects between what a headline implies or emphasizes, and what the substance of the referenced study really is. And we are beginning to see some themes that almost invariably raise our eyebrows, such as headlines that make factual claims from what are clearly preliminary results. Or headlines that–usually in a […]...
Read More
15

CMOs need to increase awareness of offerings, ISR reports

Feb 20 9:44am in-PharmaTechnologist RSS
A new set of leaders emerged in the contract manufacturing organization (CMO) industry over the past year, though many remain unheard of, according to a recent report .
Read More
59

Takeda pulls Danish paracetamol batch after two packs found to contain buprofen

Feb 20 9:44am in-PharmaTechnologist RSS
Takada Pharma A/S has recalled a batch of its Pamol paracetamol tablets in Denmark after two packs were found to contain ibuprofen.
Read More
43

New Recommendations Say All Babies Need Delayed Cord Clamping

Feb 20 9:00am Pregnancy – EverydayFamily
EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily If you're preparing to have a baby soon, there's one important thing you need to add to your to-do list: Make sure your doctor or delivery provider will practice delayed cord clamping. ... Read More EverydayFamily - Pregnancy, Baby, Child Information, Parenting Community, EverydayFamily...
Read More
15

Tilray begins shipping medical marijuana to more countries

Feb 20 6:26am in-PharmaTechnologist RSS
Medical marijuana developer Tilray has begun shipping to overseas patients and trial sites outside Canada after partnering with local distributors to comply with regional regulations.
Read More
64

Arix Bioscience raises 100m in IPO

Feb 20 2:52am PBR - News
Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange.
Read More
17

Momenta announces FDA warning letter to contracted Glatopas fill/finish manufacturer

Feb 20 2:51am PBR - News
Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the FDA.
Read More
17

Daiichi Sankyo, ArQules tivantinib fails to meet primary end point in liver cancer study

Feb 20 2:13am PBR - News
Daiichi Sankyo and ArQule announced that the tivantinib has failed to meet its primary endpoint in a phase 3 liver cancer study.
Read More
18

Judge Rules that Two Hospitals Broke Law by Not Offering Charity Care to Patients

Feb 20 12:49am Health Watched
At long last, justice came in December 2016 for former patients at Yakima Regional Medical and Cardiac Center and Toppenish Community Hospital, both in Central Washington, when the hospitals agreed to pay $4.5 million into a settlement fund to compensate those who were wrongly denied financial  assistance from 2007-2014.  Last July, Yakima County Superior Court […]...
Read More
4

Will A 5 Minute Exercise Snack Benefit Us?

Feb 19 10:35pm Pregnancy Exercise
Let’s face it, many of us tend to be ‘time poor’, days are busy and full and if in the past (pre kids) we have been able to manage an hour of exercise doing just 5-10 minutes can often seem pointless, so we don’t bother! This week on The Cafe  I was asked if I could show their viewers a […]...
Read More
19

AstraZeneca's Lynparza meets primary endpoint in breast cancer study

Feb 19 7:00pm PBR - News
A phase 3 study of AstraZeneca’s Lynparza (olaparib) met primary endpoint in a phase III trial in BRCA-mutated metastatic breast cancer.
Read More
15

<b>Bill Gates</b> Says There???s Something Worse Than Nuclear War And We???re Not Ready For It

Feb 19 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
61

Bay Area's Accused Of Smuggling Hazardous Chemicals And Conspiracy To Defraud The U.S.

Feb 19 7:00pm BioSpace.com Featured News and Stories
  Life Sciences Jobs   ...
Read More
61

Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics

Feb 19 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
63

The 10 Biggest Losers in Biopharma Last Year

Feb 19 7:00pm BioSpace.com Featured News
  Life Sciences Jobs   ...
Read More
62

Obamacare was 'flawed', but here's what health care should look like after reform: ex-Aetna CEO

Feb 19 5:03pm Health Care
Former Aetna CEO Ron Williams weighs in on what changes could be ahead for the Affordable Care Act and consumers.
Read More
16